C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume -, Issue -, Pages gfv459
Publisher
Oxford University Press (OUP)
Online
2016-04-29
DOI
10.1093/ndt/gfv459
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer® therapeutics
- (2015) Axel Vater et al. DRUG DISCOVERY TODAY
- Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus
- (2015) G. D. Fufaa et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A new chance to beat diabetic kidney disease: innate immunity and MCP-1: a matter of good and bad macrophages?
- (2015) L. Gnudi NEPHROLOGY DIALYSIS TRANSPLANTATION
- The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial
- (2015) Dick de Zeeuw et al. Lancet Diabetes & Endocrinology
- Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis
- (2014) H. J. Lambers Heerspink et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
- (2014) D. de Zeeuw et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Efficacy and Safety of Combined vs. Single Renin-Angiotensin-Aldosterone System Blockade in Chronic Kidney Disease: A Meta-Analysis
- (2013) P. Susantitaphong et al. AMERICAN JOURNAL OF HYPERTENSION
- Estimated Glomerular Filtration Rate and Albuminuria as Predictors of Outcomes in Patients With High Cardiovascular Risk
- (2013) Catherine M. Clase ANNALS OF INTERNAL MEDICINE
- Salicylate (Salsalate) in Patients With Type 2 Diabetes
- (2013) Allison B. Goldfine ANNALS OF INTERNAL MEDICINE
- 2013 ESH/ESC Guidelines for the management of arterial hypertension
- (2013) Giuseppe Mancia et al. JOURNAL OF HYPERTENSION
- Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice
- (2013) S. J. Seok et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abstract
- (2013) Kidney International Supplements
- Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
- (2012) Jun Panee CYTOKINE
- Proteinuria should be used as a surrogate in CKD
- (2012) Paolo Cravedi et al. Nature Reviews Nephrology
- An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes
- (2011) Sufyan G. Sayyed et al. KIDNEY INTERNATIONAL
- Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease
- (2010) Sara Giunti et al. Current Vascular Pharmacology
- CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice
- (2010) Young Sun Kang et al. KIDNEY INTERNATIONAL
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
- (2010) Dick de Zeeuw et al. LANCET
- Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
- (2010) Faramarz Ismail-Beigi et al. LANCET
- Assessment of kidney function in type 2 diabetes
- (2010) S Chadban et al. NEPHROLOGY
- Macrophages and Diabetic Nephropathy
- (2010) Greg H. Tesch SEMINARS IN NEPHROLOGY
- Incidence of Treatment for End-Stage Renal Disease Among Individuals With Diabetes in the U.S. Continues to Decline
- (2009) N. R. Burrows et al. DIABETES CARE
- Late Onset of Ccl2 Blockade with the Spiegelmer mNOX-E36–3′PEG Prevents Glomerulosclerosis and Improves Glomerular Filtration Rate in db/db Mice
- (2008) Volha Ninichuk et al. AMERICAN JOURNAL OF PATHOLOGY
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
- (2008) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started